Gillian Murphy
Impact in
- Cancer Research top 0.01%
- Protease and Inhibitor Mechanisms
- Immunology and Allergy top 0.01%
- Cell Adhesion Molecules Research
Papers in
- Cancer Research 247
- Protease and Inhibitor Mechanisms 247
- Oncology 165
- Peptidase Inhibition and Analysis 144
- HER2/EGFR in Cancer Research 19
- Co-authors
- Vera Knäuper (64 shared papers)Andrew Docherty (31 shared papers)John J. Reynolds (29 shared papers)Susan J. Atkinson (31 shared papers)Dylan R. Edwards (18 shared papers)Frances Willenbrock (15 shared papers)Carlos López-Otı́n (17 shared papers)Rosalind M. Hembry (20 shared papers)
- Journals
- Journal of Biological Chemistry (58 papers)Biochemical Journal (42 papers)FEBS Letters (19 papers)Journal of Cell Science (18 papers)European Journal of Biochemistry (9 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Gillian Murphy
326 papers receiving 38.4k citations
Gillian Murphy's Hit Papers
Peers
Comparison fields: 5 of 165
- Cancer Research 20.8k
- Immunology and Allergy 6.6k
- Hematology 7.2k
- Oncology 13.9k
- Rheumatology 4.0k
Countries citing papers authored by Gillian Murphy
This map shows the geographic impact of Gillian Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Murphy more than expected).
Fields of papers citing papers by Gillian Murphy
This network shows the impact of papers produced by Gillian Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Murphy. The network helps show where Gillian Murphy may publish in the future.
Co-authors
The 25 scholars most cited alongside Gillian Murphy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 327 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. Hit paper breakdown → | 1987 | 1152 |
| 2 | Metalloproteinase inhibitors: biological actions and therapeutic opportunities Hit paper breakdown → | 2002 | 972 |
| 3 | Biochemical Characterization of Human Collagenase-3 Hit paper breakdown → | 1996 | 794 |
| 4 | Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors Hit paper breakdown → | 1999 | 784 |
| 5 | Cellular Mechanisms for Human Procollagenase-3 (MMP-13) Activation Hit paper breakdown → | 1996 | 675 |
| 6 | A novel coumarin‐labelled peptide for sensitive continuous assays of the matrix metalloproteinases Hit paper breakdown → | 1992 | 656 |
| 7 | Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity Hit paper breakdown → | 1985 | 630 |
| 8 | A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2 Hit paper breakdown → | 2003 | 556 |
| 9 | Tumor Necrosis Factor-α-converting Enzyme (ADAM17) Mediates the Cleavage and Shedding of Fractalkine (CX3CL1) Hit paper breakdown → | 2001 | 556 |
| 10 | The Matrix Metalloproteinases and Their Inhibitors Hit paper breakdown → | 1992 | 547 |
| 11 | TNF‐α converting enzyme (TACE) is inhibited by TIMP‐3 Hit paper breakdown → | 1998 | 536 |
| 12 | The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A Hit paper breakdown → | 1998 | 526 |
| 13 | The Soluble Catalytic Domain of Membrane Type 1 Matrix Metalloproteinase Cleaves the Propeptide of Progelatinase A and Initiates Autoproteolytic Activation Hit paper breakdown → | 1996 | 518 |
| 14 | Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Hit paper breakdown → | 1991 | 516 |
| 15 | 1985 | 468 | |
| 16 | 2008 | 444 | |
| 17 | 1991 | 428 | |
| 18 | 1987 | 425 | |
| 19 | 1986 | 422 | |
| 20 | 1997 | 384 |
About Gillian Murphy
Gillian Murphy is a scholar working on Cancer Research, Oncology, Hematology, Molecular Biology and Immunology and Allergy, having authored 327 papers that have together received 40.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (247 papers), Peptidase Inhibition and Analysis (144 papers), Blood Coagulation and Thrombosis Mechanisms (90 papers), Cell Adhesion Molecules Research (79 papers), Signaling Pathways in Disease (49 papers), HER2/EGFR in Cancer Research (19 papers), Connective tissue disorders research (17 papers) and Enzyme Production and Characterization (16 papers). The work is most often cited by research in Cancer Research (20.8k citations), Immunology and Allergy (6.6k citations), Hematology (7.2k citations), Oncology (13.9k citations) and Rheumatology (4.0k citations). Gillian Murphy has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Vera Knäuper, Andrew Docherty, John J. Reynolds, Susan J. Atkinson, Dylan R. Edwards, Frances Willenbrock, Carlos López-Otı́n, Rosalind M. Hembry, Andrew H. Baker and Bryan Ronain Smith. Their work appears in journals such as Journal of Biological Chemistry, Biochemical Journal, FEBS Letters, Journal of Cell Science and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.